Facial basal cell carcinoma: A retrospective study of 67 cases

Table 1 Relationship of the clinical type of basal cell carcinoma with age, gender, duration, and site of the lesion in 67 patients, n (%)

Variable	Clinical type							P value
	Pigmented		Noduloulcerative		Multifocal superficial		Total
Age groups per years								0.278
≤ 60	11 (47.8)	10 (43.5)		2 (8.7)		23 (100)
> 60	13 (29.5)	23 (52.3)		8 (18.2)		44 (100)
Total	24 (35.8)	33 (49.3)		10 (14.9)		67 (100)
Gender								0.691
Male	13 (33.3)	19 (48.7)		7 (18)		39 (100)
Female	11 (39.3)	14 (50)		3 (10.7)		28 (100)
Total	24 (35.8)	33 (49.3)		10 (14.9)		67 (100)
Duration per months								0.710
< 6	15 (32.6)	24 (52.2)		7 (15.2)		46 (100)
≥ 6	9 (42.9)	9 (42.9)		3 (14.2)		21 (100)
Total	24 (35.8)	33 (49.3)		10 (14.9)		67 (100)
Site								0.605
Nose	10 (50)	7 (35)		3 (15)		20 (100)
Eyelid	4 (44.4)	5 (55.6)		0		9 (100)
Forehead	5 (31.3)	9 (56.2)		2 (12.5)		16 (100)
Scalp	3 (30)	5 (50)		2 (20)		10 (100)
Cheek	2 (16.7)	7 (58.3)		3 (25)		12 (100)
Total	24 (35.8)	33 (49.3)		10 (14.9)		67 (100)